{"disease":{"id":"fragile-x-syndrome-fxs","name":"fragile x syndrome fxs"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07439510","title":"A Study to Investigate the Effects and Safety of SPG601 for the Treatment of Fragile X Syndrome in Male Participants","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":248,"lead_sponsor_name":"Spinogenix","has_results":false},{"nct_id":"NCT02465931","title":"Decisional Capacity and Informed Consent in Fragile X Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":152,"lead_sponsor_name":"RTI International","has_results":true},{"nct_id":"NCT03862950","title":"A Trial of Metformin in Individuals With Fragile X Syndrome (Met)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"University of Alberta","has_results":false},{"nct_id":"NCT03479476","title":"A Trial of Metformin in Individuals With Fragile X Syndrome","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT07493096","title":"Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Healing Hope International","has_results":false},{"nct_id":"NCT03697161","title":"A Study of OV101 in Individuals With Fragile X Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Healx AI","has_results":true},{"nct_id":"NCT03569631","title":"A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Tetra Discovery Partners","has_results":true},{"nct_id":"NCT06677866","title":"Group CBT in Adolescents With Fragile X Syndrome and in Adolescents With Autism Spectrum Disorder","phase":"NA","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Bambino Gesù Hospital and Research Institute","has_results":false},{"nct_id":"NCT06957054","title":"Neural Biomarkers in Fragile X Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Connecta Therapeutics, S.L.","has_results":false},{"nct_id":"NCT04308954","title":"Neuroimaging GABA Physiology in Fragile X Syndrome","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":17,"lead_sponsor_name":"Stanford University","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}